Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease

References

• BrutonOCAgammaglobulinemiaPediatrics1952972272814929630
   PubMed Web of Science ®Google Scholar
• BergerMA history of immunoglobulin therapy, from the Harvard crash program to monoclonal antibodiesCurr Allergy Asthma Rep2002236837812165202
   PubMedGoogle Scholar
• OrangeJSHossnyEMWeilerCRUse of intravenous immunoglobulin in human disease; a review of the evidence by members of the primary immunodeficiency committee of the AAAAIJ Allergy Clin Immunol2006117S52555316580469
   PubMed Web of Science ®Google Scholar
• PierceCRJainNRisks associated with the use of intravenous immunoglobulinTransfus Med Rev20031724125414571392
   PubMed Web of Science ®Google Scholar
• BergerMCuppsTRFauciASImmunoglobulin replacement therapy by slow subcutaneous infusionAnn Intern Med19809355567396316
   PubMed Web of Science ®Google Scholar
• Cunningham-RundlesCSiegelFPSmithwickEMEfficacy of intravenous immunoglobulin in primary immunodeficiency diseaseAnn Intern Med19841014354396206756
   PubMed Web of Science ®Google Scholar
• QuartierPDebreMDe BlicJEarly and prolonged intravenous immunoglobulin replacement in childhood agammaglobulinemia: a retrospective survey of 31 patientsJ Pediatr199913458959610228295
   PubMed Web of Science ®Google Scholar
• WebbDBKendraJRGrossEStamatakisJDInfusion of intravenous immunoglobulin via implantable subcutaneous catheterLancet1991337161716181675753
   PubMed Web of Science ®Google Scholar
• LedermanHMRoifmanCMLaviSGelfandEWCorticosteroids for prevention of adverse reactions to intravenous immune serum globulin infusions in hypogammaglobulinemic patientsAm J Med1986814434463752145
   PubMed Web of Science ®Google Scholar
• GardulfAHammarstromLEdvard SmithCIHome treatment of hypogammaglobulinemia with subcutaneous gammaglobulin by rapid infusionLancet19913381621661712881
   PubMed Web of Science ®Google Scholar
• HansenSGustafsonRSmithCIEGardulfAExpress subcutaneous IgG infusions: decreased time of delivery with maintained safetyClin Immunol200210423724112217333
   PubMed Web of Science ®Google Scholar
• ThomasMJBrennanVMChapelHHRapid subcutaneous immunoglobulin infusions in childrenLancet1993342143214337694025
   PubMed Web of Science ®Google Scholar
• AbrahamsenTGSandersenHBustnesAHome therapy with subcutaneous immunoglobulin infusions in children with congenital immunodeficienciesPediatrics199698112711318951264
   PubMed Web of Science ®Google Scholar
• GasparJGerritsenBJonesAImmunoglobulin replacement treatment by rapid subcutaneous infusionArch Dis Child19987948519771252
   PubMed Web of Science ®Google Scholar
• StiehmERCasillasAMFinkelsteinJZSlow subcutaneous human intravenous immunoglobulin in the treatment of antibody immunodeficiency: use of an old method with a new productJ Allergy Clin Immunol19981018488499648714
   PubMed Web of Science ®Google Scholar
• MankarousMLeeMFischerSPyunKHOchsHDOxeliusVAWedgwoodRJThe half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulinJ Lab Clin Med19881126346403183495
   PubMed Web of Science ®Google Scholar
• GardulfAImmunoglobulin treatment for primary antibody deficiencies, advantages of the subcutaneous routeBiodrugs20072110511617402794
   PubMed Web of Science ®Google Scholar
• SmithGNGriffithsBMollisonDMollisonPLUptake of IgG after intramuscular and subcutaneous injectionsLancet19721120812124113191
   PubMed Web of Science ®Google Scholar
• BonillaFAPharmacokinetics of immunoglobulin administered via intravenous or subcutaneous routesImmunol Allergy Clin N Am200828803819
   PubMed Web of Science ®Google Scholar
• MooreMLQuinnJMSubcutaneous immunoglobulin replacement therapy for primary antibody deficiency: advancements into the 21st centuryAnn Allergy Asthma Immunol200810111412118727465
   PubMed Web of Science ®Google Scholar
• GardulfANicolayUMathDIChildren and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG infusions at homeJ Allergy Clin Immunol200411493694215480339
   PubMed Web of Science ®Google Scholar
• GrunebaumELevyYShoenfeldYNovel aspects of hypogammaglobulinemic states: subcutaneous immunoglobulin treatmentIsr Med Assoc J2002428828912001706
   PubMed Web of Science ®Google Scholar
• OchsHDGuptaSKiesslingPSafety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseaseJ Clin Immunol20062626527316783465
   PubMed Web of Science ®Google Scholar
• ChapelHMSpickettGPEricsonDThe comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapyJ Clin Immunol2000209410010821460
   PubMed Web of Science ®Google Scholar
• GardulfANicolayUAsensioORapid subcutaneous IgG replacement therapy is effective and safe in children and adults with primary immunodeficiencies – a prospective, multi-national studyJ Clin Immunol20062617718516758340
   PubMed Web of Science ®Google Scholar
• BergerMSubcutaneous immunoglobulin replacement in primary immunodeficienciesClin Immunol20041121715207776
   PubMed Web of Science ®Google Scholar
• GardulfAAndersenVBjorkanderJSubcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costsLancet19953453653697845120
   PubMed Web of Science ®Google Scholar
• QuintiISoresinaAAgostiniCProspective study on CVID patients with adverse reactions to intravenous or subcutaneous IgG administrationJ Clin Immunol200891699199
   Web of Science ®Google Scholar
• SundinUNavaSHammarstromLInduction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapyClin Exp Immunol19981123413469649200
   PubMed Web of Science ®Google Scholar
• FasthANystromSafety and efficacy of subcutaneous human immunoglobulin in children with primary immunodeficiencyActa Paediatrica2007961474147817850391
   PubMed Web of Science ®Google Scholar
• GardulfAAnderssonELindqistMRapid subcutaneous IgG replacement therapy at home for pregnant immunodeficient womenJ Clin Immunol20012115015411332654
   PubMed Web of Science ®Google Scholar
• AroraRNewtonTCNelsonMRSubcutaneous immunoglobulin therapy in an 11-year-old patient with common variable immunodeficiency and von Willebrand diseaseAnn Allergy Asthma Immunol20079936737017941286
   PubMed Web of Science ®Google Scholar
• RadinskySBonaguraVRSubcutaneous immunoglobulin infusion as an alternative to intravenous immunoglobulinJ Allergy Clin Immunol200311263063313679829
   PubMed Web of Science ®Google Scholar
• HogyBKeineckeHOBorteMPharmacoeconomic evaluation of immunoglobulin treatment in patients with antibody deficiencies from the perspective of the German statutory health insuranceEur J Health Econom2005502429
   Google Scholar
• GardulfABjorvellHGustafsonRThe life situations of patients with primary antibody deficiency untreated or treated with subcutaneous immunoglobulin infusionsClin Exp Immunol1993922002047683584
   PubMed Web of Science ®Google Scholar
• NicolayUKiesslingPBergerMHealth-related quality of life and treatment satisfaction in North American patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at homeJ Clin Immunol200626657216418804
   PubMed Web of Science ®Google Scholar
• GardulfANicolayUReplacement IgG therapy and self therapy at home improve the health-related quality of life in patients with primary antibody deficienciesCurr Opin Allergy Clin Immunol2006643444217088648
   PubMed Web of Science ®Google Scholar
• GardulfABorteMOchsHDPrognostic factors for health-related quality of life in adults and children with primary antibody deficiencies receiving SCIg home therapyClin Immunol2008126818817964220
   PubMed Web of Science ®Google Scholar
• FasthANystromJQuality of life and health-care resource utilization among children with primary immunodeficiency receiving home treatment with subcutaneous human immunoglobulinJ Clin Immunol20082837037818256911
   PubMed Web of Science ®Google Scholar
• DamsETMvan der MeerJWMSubcutaneous immunoglobulin replacement in patients with primary antibody deficienciesLancet19953458647898254
   PubMed Web of Science ®Google Scholar
• GustafsonRGardulfAHansenSRapid subcutaneous immunoglobulin administration every second week results in high and stable serum immunoglobulin G levels in patients with primary antibody deficienciesClin Exp Immunol200815227427918341618
   PubMed Web of Science ®Google Scholar